Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Canada Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20054
20066
20073
20081
20092
20101
20111
20122
20133
20143
20156
20163
20174
20182
20194
20201
20212
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting7
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S12
Eli Lilly and Company6
Mannkind Corporation3
Pfizer3
Sanofi3
Xeris Pharmaceuticals3
Zealand Pharma3
AstraZeneca2
Boehringer Ingelheim2
Chromaderm, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 162
Diabetes Mellitus14
Hypoglycemia10
Diabetes Mellitus, Type 24
Insulin Resistance2
Asthma1
Cardiovascular Diseases1
Diabetic Nephropathies1
Diabetic Neuropathies1
Disease1

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.